Accessibility, cost of game-changing obesity drugs problematic
However, it may not be suitable for everyone because it may interact with other medications
Cardiovascular benefits have been demonstrated in clinical trials for specific GLP-1 receptor agonists, with liraglutide, semaglutide, and dulaglutide showing reductions in major adverse cardiovascular events in patients with established cardiovascular disease or high cardiovascular risk
270 A phase 2 study (NCT05442047) is currently underway to evaluate its efficacy in ATTR-CM patients, with endpoints including the 6-minute walk test and BNP levels
Regulatory B cells improve ventricular remodeling after myocardial infarction by modulating monocyte migration
Food sensitivities are very different from food allergies, and many people are sensitive to specific food groups which can result in fatigue